Kings Path Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.1K Hold
2025
Q1
$10.6K Hold
2024
Q4
$13.5K Buy
2024
Q3
$6.59K Buy